Détails du projet
Objectif du projet
RESILIENCE-R-2023 aims to develop and test novel medical countermeasures (MCMs) against CBRNs in the framework of the three pillars of the RESILIENCE FPA multiannual action plan - Diagnosis, Prevention & Prophylaxis and Treatments. The project has the following objectives:
OB1) Design early and high-throughput diagnosis (point of care as well as reachback capabilities) of acute and late radiation-induced human health effects in preparedness of RN event,
OB2) Design of innovative decorporating and human decontaminating agents for NR threats,
OB3) Elaborate phage-based diagnostics and therapeutics for infections caused by CBRN relevant bacteria,
OB4) Design new generation vaccines against Monkeypox virus (MPXV) and Variola virus (VARV),
OB5) Design next generation of reactivators of cholinesterases against nerve agent intoxication.
Role de l'organisme
Phage therapy research and production of therapeutic phage products, including facilities.
Sources de financement
The Resilience-R project is financed by the European Commission through the European Defence Fund under grant 101168024
| Titre abrégé | First research action for Medical counter measures performed in the frame of the RESILIENCE FPA consortium |
|---|---|
| L'acronyme | RESILIENCE-R |
| statut | En cours d'exécution |
| Les dates de début/date réelle | 1/11/24 → 31/10/27 |
Partenaires de collaboration
- École royale militaire
- Commissariat à l'Énergie Atomique (CEA) (lead)
- Agencia Estatal Consejo Superior de Investigaciones Cientificas
- Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento
- AIT Austrian Institute of Technology
- German Federal Institute for Risk Assessment
- Bundesamt für Strahlenschutz
- CNRS-Paris XI
- European Research Infrastructure on Highly Pathogenic Agents
- FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
- University of Helsinki
- Institute for Radiation Protection and Nuclear Safety
- Institut für Mikrobiologie der Bundeswehr
- Institut für Pharmakologie und Toxikologie der Bundeswehr
- Institut für Radiobiologie der Bundeswehr
- Institut national de la santé et de la recherche médicale
- Institut Pasteur, Paris
- Institut za medicinska istraživanja i medicinu rada
- Invitris GmbH
- JAFRAL
- Johann Wolfgang Goethe University
- KU Leuven
- University of Latvia
- MB Pharma
- microfluidic ChipShop
- Ministère des Armées
- TNO Defence Security and Safety (NL)
- Nemzeti Népegészségügyi Központ
- OPGS PHARMACEUTICALS
- Riga Stradiņš University
- Totalförsvarets Forskningsinstitut (Swedish Defence Research Agency)
- Campus UAB
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Université d'Orléans
- University of Rouen Normandy
- Université Paris-Cité
- University of Ghent
- University of Hradec Králové
- Univerzita obrany
- Uniwersytet Gdański
- University of Wrocław
- Valneva SE
Empreinte digitale
Explorez les thèmes de recherche abordés par ce projet. Ces libellés sont générés sur la base des prix/subventions sous-jacents. Ensemble, ils forment une empreinte digitale unique.